Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases.
| Website: | www.horizonpharma.com |
| Email: | investor-relations@horizonpharma.com |
| Main Phone: | +353 17722100 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House, 1st Floor |
| City / Town: | Dublin 4 |
| Country: | IRL |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Timothy P. Walbert |
| Employees: | 1010 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 17.52 | Change $ -0.11 | Change % -0.62 | Tick N/A |
| Bid 17.51 | Bid Size 600.00 | Ask 17.52 | Ask Size 600.00 |
| Open 17.67 | High 17.76 | Low 17.41 | Prev Close 17.63 |
| Last Trade | Volume 1.8 mi | 52 Wk Hi 18.23 | 52 Wk Low 11.17 |
| Market Cap 2.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 165,041,063.00 | EPS (TTM) -2.92 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 36 | 64 |
| Number of Buys | 18 | 32 |
| Number of Sells | 18 | 32 |
| Net Activity | 242822 | 343770 |
| Last 10 Buys | Shares |
|---|---|
| Michael G. Grey | 1,000 |
| H. Thomas Watkins | 1,000 |
| H. Thomas Watkins | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brian K. Beeler | 1,000 |
| Brian K. Beeler | 1,000 |
| Timothy P. Walbert | 1,000 |
| Brian K. Beeler | 1,000 |
| Robert F. Carey | 1,000 |
| Robert F. Carey | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Virinder Nohria | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 24 | 24 | 24 | 24 |
| Low Target Price Estimate | 16 | 16 | 16 | 16 |
| Mean Target Price Estimate | 20 | 20 | 20 | 20 |
| Standard Deviation | 3.21 | 3.21 | 3.21 | 3.21 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| CT ORDER | 1 | 2018-05-14 | |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 112 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1.29 | 1.29 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
